Home › Funds › RA CAPITAL MANAGEMENT, L.P. › EWTX

RA CAPITAL MANAGEMENT, L.P. position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 8,392,730 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$341.0M, representing 2.96% of its reported portfolio and ranking #7 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed EWTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)8.39M sh
Reported value held$341.00M
Portfolio Weight2.96%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s EWTX position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in EWTX in Q1 2024 at 8,909,091 shares (US$162.5M). The position peaked in Q2 2026 at 8,392,730 shares, worth US$341.0M. Across 10 filings, RA CAPITAL MANAGEMENT, L.P. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 8,392,730 shares valued at US$341.0M — a reduction of -2,035,707 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2024 8.91M $162.50M New
Q2 2024 8.91M $160.45M Hold
Q3 2024 8.91M $237.78M Hold
Q4 2024 8.91M $237.87M Hold
Q1 2025 8.91M $196.00M Hold
Q2 2025 9.90M $129.82M Add
Q3 2025 10.43M $169.15M Add
Q4 2025 10.43M $258.78M Hold
Q1 2026 10.43M $328.50M Hold
Q2 2026 8.39M $341.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), Novo Holdings A/S (US$217.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held EWTX?

RA CAPITAL MANAGEMENT, L.P. has disclosed EWTX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in EWTX?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 8.39M shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $341.00M, representing 2.96% of its reported portfolio and ranking #7.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling EWTX?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in EWTX. The position peaked in Q2 2026 at 8.39M shares.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, Novo Holdings A/S, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.